← Back to Patent Explorer
US4769362A Expired / Lapsed US ⏱️ 0.0 years remaining

Increased vascular perfusion following administration of lipids

Assignee: ANGIO-MEDICAL Corp
•
Filing: 1986-04-14
•
Granted: 1988-09-06
•
Expires: 2006-04-14
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Lipid containing molecules and compositions, including gangliosides and omental tissue extracts had previously been found to be effective in increasing angiogenesis. It has now been found that these same materials cause increased localized perfusion in mammals. A method for providing increased perfusion, using these compositions, is presented herein.

Inventors

  • 👤 Nicholas Catsimpoolas
  • 👤 Robert McCluer
  • 👤 James Evans
  • 👤 Robert S. Sinn

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-29 04:53
CPC Classifications
C; C07; C07H; C07H15/00; C07H15/02; C07H15/04; C07H15/10; A; A61; A61K; A61K31/00; A61K31/66; A61K31/683; A61K31/685; A61K31/70; A61K31/715; A61K35/00; A61K35/12; A61K35/37; A61K35/38; A61P; A61P7/00; A61P9/00; A61P9/14

Claims Analysis

Total Claims: 16
Claim 1
Independent Claim 38 words
A method of improving localized vascular perfusion in mammals comprising administering to a mammal in need of improved localized vascular perfusion a therapeutically effective amount of a composition containing angiogenically effective lipid-containing molecules and a pharmaceutically acceptable carrier.
Claim 2
Independent Claim 38 words
A method of improving localized vascular perfusion in mammals comprising administering to a mammal in need of improved localized vascular perfusion a therapeutically effective amount of a composition containing angiogenically effective lipid-containing molecules and a pharmaceutically acceptable carrier.
Claim 3
Dependent Claim 16 words
A method as in claim 1, wherein said composition comprises an extract of mammalian omental tissue.
Claim 4
Dependent Claim 11 words
A method as in claim 1, wherein said composition comprises gangliosides.
Claim 5
Dependent Claim 12 words
A method as in claim 3, wherein said composition is administered intravenously.
Claim 6
Dependent Claim 17 words
A method as in claim 3, wherein said composition comprises a mixture of mono-, di-, and tri-sialogangliosides.
Claim 7
Dependent Claim 21 words
A method as in claim 5, wherein said mixture comprises mono-, di-, and tri-sialogangliosides in a ratio of 1:1:1 by weight.
Claim 8
Dependent Claim 16 words
A method as in claim 3, wherein said composition comprises a mixture of di- and tri-sialogangliosides.
Claim 9
Dependent Claim 19 words
A method as in claim 7, wherein said di- and tri-sialogangliosides are in a ratio of 1:2 by weight.
Claim 10
Dependent Claim 14 words
A method as in claim 3, wherein said mixture further comprises omental neutral lipids.
Claim 11
Dependent Claim 27 words
A method as in claim 1, wherein said composition is administered in an amount up to about 500 mg per kg of body weight of said mammal.
Claim 12
Independent Claim 14 words
A method as in claims 1 or 3, wherein said composition is administered subcutaneously.
Claim 13
Independent Claim 14 words
A method as in claims 1 or 3, wherein said composition is administered intramuscularly.
Claim 14
Dependent Claim 18 words
A method as in claim 1, wherein said composition comprises a mixture of mammalian omental extract and gangliosides.
Claim 15
Dependent Claim 27 words
A method as in claim 1, wherein said composition is administered to said mammal at a site removed from a site where improved vascular perfusion is desired.
Claim 16
Dependent Claim 20 words
A method as in claim 14, wherein said composition is administered to said mammal at a site of traumatized tissue.

References Cited (Backward Citations)

US4347244A Cited
US4456596A Cited
US4476119A Cited
EP0146810A2 Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1991-09-06 1992-03-07 1992-09-06 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1995-09-06 1996-03-07 1996-09-06 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1999-09-06 2000-03-07 2000-09-06 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag